Md Nur Alam1, Partha Das1, Tripti De1, Tapati Chakraborti2. 1. Department of Biochemistry and Biophysics, University of Kalyani, Nadia 741235, West Bengal, India. 2. Department of Biochemistry and Biophysics, University of Kalyani, Nadia 741235, West Bengal, India. Electronic address: t_chakra08@rediffmail.com.
Abstract
AIMS: This study aims to identify, purify, and characterize an endogenous serine protease inhibitor from an Indian strain of Leishmania donovani, which causes the fatal visceral leishmaniasis. MAIN METHODS: (i) Reverse zymography was used to identify the serine protease inhibitor by inhibiting the gelatinolytic activity of serine protease. (ii) Purification was performed by combining heat treatment, ultracentrifugation, and affinity and gel permeation chromatography. (iii) Spectrophotometric assays were conducted to quantify and compare the inhibitory activity of the L. donovani serine protease inhibitor (LdISP). (iv) Further, the protein was identified by matrix-assisted laser desorption/ionization (MALDI) time-of-flight (ToF) mass spectrometry (MS). KEY FINDINGS: An endogenous inhibitor with an apparent molecular weight of 21.8 kDa, which is acidic in nature, having a pI of 5.9 was identified. The Ki value of the inhibitor for trypsin was determined to be in the nanomolar range. The protein has the following features: (i) ecotin-like nature, (ii) cross-organism functionality, that is, an inhibitory effect on the serine proteases of higher organisms other than its own, and (iii) homology with other such proteins from a different species of Leishmania on conducting protein mass fingerprinting after MALDI ToF MS. SIGNIFICANCE: The inhibitor shows varying and entirely contrasting efficacies toward serine proteases of its own as well as of higher organisms. This indicates that it accelerates disease progression and drives parasite survival as it inhibits the activities of the host serine proteases.
AIMS: This study aims to identify, purify, and characterize an endogenous serine protease inhibitor from an Indian strain of Leishmania donovani, which causes the fatal visceral leishmaniasis. MAIN METHODS: (i) Reverse zymography was used to identify the serine protease inhibitor by inhibiting the gelatinolytic activity of serine protease. (ii) Purification was performed by combining heat treatment, ultracentrifugation, and affinity and gel permeation chromatography. (iii) Spectrophotometric assays were conducted to quantify and compare the inhibitory activity of the L. donovani serine protease inhibitor (LdISP). (iv) Further, the protein was identified by matrix-assisted laser desorption/ionization (MALDI) time-of-flight (ToF) mass spectrometry (MS). KEY FINDINGS: An endogenous inhibitor with an apparent molecular weight of 21.8 kDa, which is acidic in nature, having a pI of 5.9 was identified. The Ki value of the inhibitor for trypsin was determined to be in the nanomolar range. The protein has the following features: (i) ecotin-like nature, (ii) cross-organism functionality, that is, an inhibitory effect on the serine proteases of higher organisms other than its own, and (iii) homology with other such proteins from a different species of Leishmania on conducting protein mass fingerprinting after MALDI ToF MS. SIGNIFICANCE: The inhibitor shows varying and entirely contrasting efficacies toward serine proteases of its own as well as of higher organisms. This indicates that it accelerates disease progression and drives parasite survival as it inhibits the activities of the host serine proteases.
Authors: Mauricio S Peña; Guilherme C Cabral; Wesley L Fotoran; Katia R Perez; Beatriz S Stolf Journal: Cell Death Dis Date: 2017-03-02 Impact factor: 8.469
Authors: Bruna T Dias; Karina Luisa Dias-Teixeira; Joseane P Godinho; Marilia S Faria; Teresa Calegari-Silva; Maowia M Mukhtar; Ulisses Lopes; Jeremy C Mottram; Ana Paula C A Lima Journal: FASEB J Date: 2019-07-05 Impact factor: 5.191
Authors: Bárbara B Esteves; Marcella N Melo-Braga; Vladimir Gorshkov; Thiago Verano-Braga; Martin R Larsen; Célia M F Gontijo; Patricia F Quaresma; Helida M Andrade Journal: Front Cell Infect Microbiol Date: 2022-02-15 Impact factor: 5.293
Authors: Zoltán Attila Nagy; Dávid Szakács; Eszter Boros; Dávid Héja; Eszter Vígh; Noémi Sándor; Mihály Józsi; Gábor Oroszlán; József Dobó; Péter Gál; Gábor Pál Journal: PLoS Pathog Date: 2019-12-20 Impact factor: 6.823